Paris, May 7th 2009 - Bryan, Garnier & Co, the independent pan-European investment bank focused on growth companies, today announced the secondary placement of Trace One shares which were held by historical financial shareholders of the company and included investment funds Siparex Ventures, SGAM AI, A Plus Finance, CDC Entreprises, Equitis and I-Source Gestion.
The operation allowed Trace One to attract 3 new capital development investors, namely, Oddo Asset Management, Tempo Capital and OTC Asset Management. Bryan, Garnier & Co acted as sole financial advisor to Trace One's management and shareholders.
Trace One is a leading international software company specialising in
collaborative on-demand Product Lifecycle Management (PLM) solutions in SaaS
mode (Software as a Service) for the retail and consumer goods industries.
Trace One's Product Management Suite (PMS) enables retailers and brand owners
to industrially manage the development of private label products
collaboratively with their extended enterprise to gain efficiency. Based on
state-of-the-art collaborative document and project management features, PMS
comprises a portfolio of on-demand Web-based solutions allowing immediate
roll-out, covering products development, quality and packaging management.
Trace One customers include retail industry leaders such as Carrefour, Auchan
and more than 1,000 companies in the international consumer goods market.
The new investors will support Trace One's growth into new regions, and help the company continue to innovate and develop cutting-edge collaborative PLM solutions in SaaS mode for manufacturers and retailers of Consumer Packaged Goods.
Bruno Tourme, Managing Director at Bryan, Garnier & Co in Head of Technology and lead on the transaction commented: "We see Trace One as one of the most promising European SaaS providers of collaborative PLM retail solutions. The company has a pioneering vision of the sector and has also proven its ability to execute a significant and sustainable growth. This successful transaction demonstrates the ability of our experienced investment bankers to provide industry-specific advice and deliver solutions to our clients despite a challenging financial environment. It confirms our position as a leading European investment bank in Software and a leader worldwide in retail technologies."
Henri-Pierre Jeancard, Director at Bryan, Garnier & Co in charge of private equity and capital markets financing, added: "The context in which this transaction took place, paired with Trace One's strong growth profile, required much flexibility and creativity in the structuring. We are very proud to have delivered it to the satisfaction of all parties."
Following the sale of AS Groupe to Lefebvre Software, of Civitas to Cegid, the equity funding for Jobpartners, the sale of Infolog Solutions to Generix and of Orsyp to Argos Soditic, this transaction confirms Bryan, Garnier & Co' status as a leading investment bank in the area of Technology, and particularly in Application Software. Trace One was one of the first applications providers in Europe to implement a Software-as-a-Service (SaaS) business model. This model, which provides vendors with strong visibility and a steady flow of recurring revenues, is expected to gain widespread adoption over the coming years. Bryan, Garnier & Co is therefore very proud to be part of the emergence and strong development of such a dynamic and innovating company as Trace One.
Jérôme Malavoy, Chief Executive Officer of Trace One, added: "We worked for several months with Bryan Garnier within a highly unstable capital market. We evaluated various alternatives throughout the process ensuring that we select the most appropriate financing for the company. Bryan Garnier's unique commitment at each stage of the process and its large scope of financing and secondary solutions has enabled us to seize the most adequate structure with the best possible partners. Bryan, Garnier & Co's strong understanding of retail software business was primordial. It enabled us to carry out this transaction in an extremely complicated financial environment. Overall, Bryan, Garnier & Co's intervention combined a strong coordination of the transactional process with senior involvement and broad investors' network."
Professionals involved in this transaction:
Bruno Tourme Managing Director - Head of Technology Group
+44 207 332 2551 | email@example.com
Henri-Pierre Jeancard Director – Head of Capital Markets Financing
+33 1 56 68 75 97 | firstname.lastname@example.org
Guillaume Cauchoix Senior Analyst - Corporate Finance
+33 1 56 68 75 87 | email@example.com
About Trace One
The process virtualization solutions today offer companies valuable aid in their search for improved efficiency and productivity. These solutions enable the costs of processing administrative and technical data to be reduced considerably, the collaborative processes made more fluent, a large number of projects to be managed in parallel and the time-to-launch of new products to be reduced.
The choice of the SaaS mode (application in hosted mode) complements the benefits of process virtualization with rapidity of deployment, pooled infrastructure costs (human and material), enhanced security, transparent administration, automatic upgrades and considerable time savings in general. Trace One markets its solutions under two distinct brands: Trace One for its private label product management solutions and Catalogic for its product data sheet management and retail network organization solutions.
About Bryan, Garnier & Co
Bryan, Garnier & Co is an independent investment bank
specialising in European TMT, Healthcare and Renewable Energies growth
companies. Bryan, Garnier & Co is positioned in three activities: Equity
Research & Brokerage, Asset Management and Corporate Finance.
With more than 80 professionals based in London, Paris and Geneva, Bryan, Garnier & Co combines the range of services and the expertise of top-tier investment banks with the level of attention to clients of a boutique.
The Corporate Finance department of Bryan, Garnier & Co advises European privately or publicly-owned companies, entrepreneurs and financial investors in the following transactions:
- Equity Capital Markets transactions
- Private Placements
- Merger & Acquisitions
Over the past 10 years, Bryan, Garnier & Co has become a
specialist as a reference point vis-à-vis venture capital funds and seed
capital funds for cross-border Private Placements in technology companies.
In addition, Bryan, Garnier & Co took an increasingly active role in European capital markets, acting as financial advisor on the following transactions:
- €10m private placement on behalf of Initiatives & Développements (ALIDA)
- €10m private placement on behalf of Inspirational Stores
- €11.5m private placement in the form of a convertible bond for GoAdv (GOAOC)
- €8m in mezzanine financing for Orolia (ALORO)
- Placement of the international tranche of a €28m convertible bond for Arkimedica (ARK)
- €12m IPO on behalf of Ipsogen (ALIPS)
- €11m fundraising on behalf of Job Partners
- €7m follow-on offering on behalf of Medicrea (ALMED)
- €53m follow-on offering on behalf of Risc Group (RSC)
- €40m follow-on offering on behalf of Bioalliance (BIO)
- €100m follow-on offering on behalf of Transgene (TSG)
- Secondary placement of €45m on behalf of Parrot (PARRO)
- Capital increase of €66m on behalf of Sword Group (SWP)
The most recent transactions for which Bryan, Garnier & Co acted as advisor are the following:
- Acquisition of Carlogo and Attracteam by Quadriplay Advertainment, Financial Advisor to the Sellers
- Acquisition of AS Groupe by Lefebvre Software, Sole Advisor of the Transaction
- Acquisition of the French, Italian and Spanish subsidiaries of Payzone by Proximania, Financial Advisor to the Acquirer
- Acquisition of VCS Timeless by Cegid, Financial Advisor to the Sellers
- Acquisition of Civitas by Cegid, Financial Advisor to the Sellers
- Acquisition of Infolog Solutions by Generix, Vendor Financial Advisor
- Sale of Cosmos-Bay Vectis to Solucom, Vendor Financial AdvisorSale of Orsyp to its Management and Argos Soditic through a LBO, Vendor Financial Advisor
Bryan, Garnier & Co is authorised and regulated by the Financial Services Authority (FSA) in the United Kingdom, and is member of London Stock Exchange and Euronext, Alternext Listing Sponsor, and is active on all European Capital Markets.